NRXS 8-K 2026-10-14

Neuraxis, INC (NRXS) 8-K dated 2026-10-14 — accession 0001493152-26-047034. This URL is the filing, not the NRXS hub.

Neuraxis, INC (NRXS) is a biotechnology company listed on AMEX.

Neuraxis, INC filed a 8-K on 2026-10-14. Accession 0001493152-26-047034.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.

Not investment advice. The NRXS SEC hub lists recent forms. The stock page is the research view.